We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Combination Treatment Offers Better Option for Colon Cancer Patients

By MedImaging International staff writers
Posted on 05 Jan 2022
Print article
Image: TheraSphere microscopic glass beads containing yttrium-90 (Photo courtesy of Boston Scientific)
Image: TheraSphere microscopic glass beads containing yttrium-90 (Photo courtesy of Boston Scientific)
Targeted radioembolization (TARE) alongside chemotherapy improves progress-free survival for patients with colorectal liver metastases (CLM), according to a new study.

Researchers at Northwestern University (NU; Evanston, IL, USA), the University of California, Los Angeles (UCLA; USA), and other institutions conducted an international, multicenter, open-label phase III trial of 428 patients with CLM randomly assigned to receive second-line systemic chemotherapy (with or without transarterial Yttrium-90 TARE) on a 1:1 basis. The two primary end points were progression-free survival (PFS) and hepatic PFS (hPFS), assessed by blinded independent central review.

The results showed that the patients receiving a combination of chemotherapy and TARE had longer progression-free survival, but did not improve overall survival. Some subsets of patients had greater benefit from TARE than others; characteristics which could identify patients who could benefit from addition of TARE were the location of the original colon tumor, genetic make-up of the tumor, and the amount of tumor in the liver. Importantly, the addition of TARE did not impact ability to receive subsequent therapy. The study was published on December 10, 2021, in the Journal of Clinical Oncology.

“Most patients with CLM are poor candidates for resection surgery. The cancer is either distributed in a way that it can't be operated on safely, or the size of the lesions makes it impossible,” said lead author professor Mary Mulcahy, MD, of NU. “We know systemic chemotherapy will ultimately fail, so we're looking for non-surgical therapy that can address these patients. This new treatment could be a better option compared to chemotherapy alone.”

TARE involves glass microspheres, within which a radioactive isotope (yttrium-90) is embedded. As healthy liver tissue is mainly perfused by the portal vein, TARE can be selectively administered to the tumors. The microspheres lodge in the small vessels of the tumor (embolization), emitting localized radiation therapy to targeted segments, results in tissue necrosis. The yttrium-90, with a half-life of 3.85 days, decays to Zirconium-90.

Related Links:
Northwestern University
University of California, Los Angeles


Gold Supplier
SBRT Phantom with Removable Spine
E2E SBRT Phantom with Removable Spine Model 036S-CVXX-xx
New
Medical Software
Bladder Scanner Graphics Workstation Software
Motorized DR System I-Arm
Alizé BRS
New
Ultrasound Probe Covers
Intuit

Print article
Radcal

Channels

MRI

view channel
Image: MRI scan showing the fetus and placental compartments (Photo courtesy of WUSTL)

New MRI Method Automatically Detects Placental Health during Pregnancy

Early monitoring of the placenta can improve detection and prevention of pregnancy complications, such as preterm birth, fetal growth disorders and preeclampsia. Currently, standard MRI analysis methods... Read more

Ultrasound

view channel
Image: The new Clarius MSK AI model speeds up diagnosis and treatment of musculoskeletal injuries (Photo courtesy of Clarius)

Handheld MSK Ultrasound Scanner Uses AI to Automatically Identify and Measure Tendons in Foot, Ankle and Knee

An artificial intelligence (AI) application for musculoskeletal (MSK) imaging that works with handheld point-of-care ultrasound devices automatically identifies, highlights, and measures tendon structures... Read more

General/Advanced Imaging

view channel
Image: CZT gamma detector for SPECT imaging (Photo courtesy of Kromek)

Low-Dose Molecular Breast Imaging (MBI) Could Improve Cancer Detection in Dense Breast Tissue

Traditional mammography is often less able to clearly image tumors due to the density of the breast tissue. Molecular breast imaging (MBI) technology uses a radioactive tracer that ‘lights up’ areas of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.